A Randomized, Phase II, Controlled Trial Comparing the Efficacy of Adefovir Dipivoxil and Tenofovir Disoproxil Fumarate for the Treatment of Lamivudine-Resistant Hepatitis B Virus in Subjects Who Are Co-Infected With HIV.

Trial Profile

A Randomized, Phase II, Controlled Trial Comparing the Efficacy of Adefovir Dipivoxil and Tenofovir Disoproxil Fumarate for the Treatment of Lamivudine-Resistant Hepatitis B Virus in Subjects Who Are Co-Infected With HIV.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 May 2012

At a glance

  • Drugs Adefovir dipivoxil; Tenofovir disoproxil fumarate
  • Indications Hepatitis B; HIV infections; HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Apr 2012 Planned number of patients changed from 53 to 90 as reported by ClinicalTrials.gov.
    • 21 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top